Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPH4336 in Locally Advanced or Metastatic Liposarcomas
NCT05580588Phase 2Terminated
- Sponsor
- Shanghai Pharmaceuticals Holding Co Ltd
- Start
- Aug 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SPH4336 in Liposarcoma, sponsored by Shanghai Pharmaceuticals Holding Co Ltd. Started Aug 2023; status: terminated.
02
Drugs
SPH4336
03
Conditions
Liposarcoma
Beyond the preview
Go deeper on NCT05580588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05580588.